ID   PK3C3_HUMAN             Reviewed;         887 AA.
AC   Q8NEB9; Q15134;
DT   06-DEC-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2002, sequence version 1.
DT   10-MAY-2017, entry version 147.
DE   RecName: Full=Phosphatidylinositol 3-kinase catalytic subunit type 3;
DE            Short=PI3-kinase type 3;
DE            Short=PI3K type 3;
DE            Short=PtdIns-3-kinase type 3;
DE            EC=2.7.1.137;
DE   AltName: Full=Phosphatidylinositol 3-kinase p100 subunit;
DE   AltName: Full=Phosphoinositide-3-kinase class 3;
DE   AltName: Full=hVps34;
GN   Name=PIK3C3 {ECO:0000312|HGNC:HGNC:8974};
GN   Synonyms=VPS34 {ECO:0000305};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, COFACTOR, SUBUNIT, TISSUE
RP   SPECIFICITY, AND INTERACTION WITH PIK3R4.
RX   PubMed=7628435;
RA   Volinia S., Dhand R., Vanhaesebroeck B., MacDougall L.K.,
RA   Zvelebil M.J., Domin J., Panaretou C., Waterfield M.D.;
RT   "A human phosphatidylinositol 3-kinase complex related to the yeast
RT   Vps34p-Vps15p protein sorting system.";
RL   EMBO J. 14:3339-3348(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Testis, and Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3] {ECO:0000305}
RP   FUNCTION, INTERACTION WITH RAB7A AND PIK3R4, AND SUBCELLULAR LOCATION.
RX   PubMed=14617358; DOI=10.1034/j.1600-0854.2003.00133.x;
RA   Stein M.P., Feng Y., Cooper K.L., Welford A.M., Wandinger-Ness A.;
RT   "Human VPS34 and p150 are Rab7 interacting partners.";
RL   Traffic 4:754-771(2003).
RN   [4]
RP   INTERACTION WITH NCKAP1L.
RX   PubMed=16417406; DOI=10.1371/journal.pbio.0040038;
RA   Weiner O.D., Rentel M.C., Ott A., Brown G.E., Jedrychowski M.,
RA   Yaffe M.B., Gygi S.P., Cantley L.C., Bourne H.R., Kirschner M.W.;
RT   "Hem-1 complexes are essential for Rac activation, actin
RT   polymerization, and myosin regulation during neutrophil chemotaxis.";
RL   PLoS Biol. 4:E38-E38(2006).
RN   [5]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [6]
RP   INTERACTION WITH BECN1 AND ATG14.
RX   PubMed=19050071; DOI=10.1073/pnas.0810452105;
RA   Sun Q., Fan W., Chen K., Ding X., Chen S., Zhong Q.;
RT   "Identification of Barkor as a mammalian autophagy-specific factor for
RT   Beclin 1 and class III phosphatidylinositol 3-kinase.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:19211-19216(2008).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-261, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [8]
RP   FUNCTION, AND SUBUNIT.
RX   PubMed=20643123; DOI=10.1016/j.yexcr.2010.07.008;
RA   Thoresen S.B., Pedersen N.M., Liestol K., Stenmark H.;
RT   "A phosphatidylinositol 3-kinase class III sub-complex containing
RT   VPS15, VPS34, Beclin 1, UVRAG and BIF-1 regulates cytokinesis and
RT   degradative endocytic traffic.";
RL   Exp. Cell Res. 316:3368-3378(2010).
RN   [9]
RP   INTERACTION WITH BECN1; RUBCN; ATG14; PIK3R4 AND UVRAG.
RX   PubMed=19270696; DOI=10.1038/ncb1846;
RA   Matsunaga K., Saitoh T., Tabata K., Omori H., Satoh T., Kurotori N.,
RA   Maejima I., Shirahama-Noda K., Ichimura T., Isobe T., Akira S.,
RA   Noda T., Yoshimori T.;
RT   "Two Beclin 1-binding proteins, Atg14L and Rubicon, reciprocally
RT   regulate autophagy at different stages.";
RL   Nat. Cell Biol. 11:385-396(2009).
RN   [10]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=20208530; DOI=10.1038/ncb2036;
RA   Sagona A.P., Nezis I.P., Pedersen N.M., Liestol K., Poulton J.,
RA   Rusten T.E., Skotheim R.I., Raiborg C., Stenmark H.;
RT   "PtdIns(3)P controls cytokinesis through KIF13A-mediated recruitment
RT   of FYVE-CENT to the midbody.";
RL   Nat. Cell Biol. 12:362-371(2010).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [12]
RP   INTERACTION WITH SLAMF1.
RX   PubMed=22493499; DOI=10.1074/jbc.M112.367060;
RA   Ma C., Wang N., Detre C., Wang G., O'Keeffe M., Terhorst C.;
RT   "Receptor signaling lymphocyte-activation molecule family 1 (Slamf1)
RT   regulates membrane fusion and NADPH oxidase 2 (NOX2) activity by
RT   recruiting a Beclin-1/Vps34/ultraviolet radiation resistance-
RT   associated gene (UVRAG) complex.";
RL   J. Biol. Chem. 287:18359-18365(2012).
RN   [13]
RP   INTERACTION WITH BECN1P1/BECN2.
RX   PubMed=23954414; DOI=10.1016/j.cell.2013.07.035;
RA   He C., Wei Y., Sun K., Li B., Dong X., Zou Z., Liu Y., Kinch L.N.,
RA   Khan S., Sinha S., Xavier R.J., Grishin N.V., Xiao G., Eskelinen E.L.,
RA   Scherer P.E., Whistler J.L., Levine B.;
RT   "Beclin 2 functions in autophagy, degradation of G protein-coupled
RT   receptors, and metabolism.";
RL   Cell 154:1085-1099(2013).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-282, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [15]
RP   INTERACTION WITH BECN1.
RX   PubMed=23878393; DOI=10.1128/MCB.00079-13;
RA   Fogel A.I., Dlouhy B.J., Wang C., Ryu S.W., Neutzner A., Hasson S.A.,
RA   Sideris D.P., Abeliovich H., Youle R.J.;
RT   "Role of membrane association and Atg14-dependent phosphorylation in
RT   beclin-1-mediated autophagy.";
RL   Mol. Cell. Biol. 33:3675-3688(2013).
RN   [16]
RP   RECONSTITUTION OF THE PI3K COMPLEX I, AND ELECTRON MICROSCOPY OF THE
RP   PI3K COMPLEX I.
RX   PubMed=25490155; DOI=10.7554/eLife.05115;
RA   Baskaran S., Carlson L.A., Stjepanovic G., Young L.N., Kim do J.,
RA   Grob P., Stanley R.E., Nogales E., Hurley J.H.;
RT   "Architecture and dynamics of the autophagic phosphatidylinositol 3-
RT   kinase complex.";
RL   Elife 3:0-0(2014).
CC   -!- FUNCTION: Catalytic subunit of the PI3K complex that mediates
CC       formation of phosphatidylinositol 3-phosphate; different complex
CC       forms are believed to play a role in multiple membrane trafficking
CC       pathways: PI3KC3-C1 is involved in initiation of autophagosomes
CC       and PI3KC3-C2 in maturation of autophagosomes and endocytosis.
CC       Involved in regulation of degradative endocytic trafficking and
CC       required for the abcission step in cytokinesis, probably in the
CC       context of PI3KC3-C2 (PubMed:20643123, PubMed:20208530). Involved
CC       in the transport of lysosomal enzyme precursors to lysosomes.
CC       Required for transport from early to late endosomes (By
CC       similarity). {ECO:0000250|UniProtKB:O88763,
CC       ECO:0000269|PubMed:14617358, ECO:0000269|PubMed:20208530,
CC       ECO:0000269|PubMed:20643123, ECO:0000269|PubMed:7628435,
CC       ECO:0000305}.
CC   -!- CATALYTIC ACTIVITY: ATP + 1-phosphatidyl-1D-myo-inositol = ADP +
CC       1-phosphatidyl-1D-myo-inositol 3-phosphate.
CC   -!- COFACTOR:
CC       Name=Mn(2+); Xref=ChEBI:CHEBI:29035;
CC         Evidence={ECO:0000269|PubMed:7628435};
CC   -!- SUBUNIT: Component of the PI3K (PI3KC3/PI3K-III/class III
CC       phosphatidylinositol 3-kinase) complex the core of which is
CC       composed of the catalytic subunit PIK3C3, the regulatory subunit
CC       PIK3R4 and BECN1 associating with additional regulatory/auxilliary
CC       subunits to form alternative complex forms. Alternative complex
CC       forms containing a forth regulatory subunit in a mutually
CC       exclusive manner are: the PI3K complex I (PI3KC3-C1) containing
CC       ATG14, and the PI3K complex II (PI3KC3-C2) containing UVRAG.
CC       PI3KC3-C1 displays a V-shaped architecture with PIK3R4 serving as
CC       a bridge between PIK3C3 and the ATG14:BECN1 subcomplex. Both,
CC       PI3KC3-C1 and PI3KC3-C2, can associate with further regulatory
CC       subunits such as RUBCN, SH3GLB1/Bif-1 and AMBRA1 (PubMed:7628435,
CC       PubMed:19050071, PubMed:20643123, PubMed:19270696,
CC       PubMed:23878393, PubMed:25490155). PI3KC3-C1 probably associates
CC       with PIK3CB (By similarity). Interacts with RAB7A in the presence
CC       of PIK3R4 (PubMed:14617358). Interacts with AMBRA1 (By
CC       similarity). Interacts with BECN1P1/BECN2 (PubMed:23954414).
CC       Interacts with SLAMF1(PubMed:22493499). May be a component of a
CC       complex composed of RAB5A (in GDP-bound form), DYN2 and PIK3C3 (By
CC       similarity). Interacts with NCKAP1L (PubMed:16417406).
CC       {ECO:0000250|UniProtKB:Q6PF93, ECO:0000250|UniProtKB:Q9TXI7,
CC       ECO:0000269|PubMed:14617358, ECO:0000269|PubMed:16417406,
CC       ECO:0000269|PubMed:19050071, ECO:0000269|PubMed:19270696,
CC       ECO:0000269|PubMed:20643123, ECO:0000269|PubMed:22493499,
CC       ECO:0000269|PubMed:23878393, ECO:0000269|PubMed:23954414,
CC       ECO:0000269|PubMed:25490155, ECO:0000269|PubMed:7628435,
CC       ECO:0000305}.
CC   -!- INTERACTION:
CC       Q6ZNE5:ATG14; NbExp=21; IntAct=EBI-1056470, EBI-2690371;
CC       Q14457:BECN1; NbExp=24; IntAct=EBI-1056470, EBI-949378;
CC       Q96F24:NRBF2; NbExp=11; IntAct=EBI-1056470, EBI-2362014;
CC       Q92622:RUBCN; NbExp=7; IntAct=EBI-1056470, EBI-2952709;
CC       Q9P2Y5:UVRAG; NbExp=16; IntAct=EBI-1056470, EBI-2952704;
CC   -!- SUBCELLULAR LOCATION: Midbody {ECO:0000269|PubMed:20208530}. Late
CC       endosome {ECO:0000269|PubMed:14617358}. Cytoplasmic vesicle,
CC       autophagosome {ECO:0000305|PubMed:14617358}. Note=As component of
CC       the PI3K complex I localized to pre-autophagosome structures. As
CC       component of the PI3K complex II localized predominantly to
CC       endosomes (Probable). Localizes also to discrete punctae along the
CC       ciliary axoneme and to the base of the ciliary axoneme (By
CC       similarity). {ECO:0000250|UniProtKB:Q6PF93,
CC       ECO:0000305|PubMed:14617358}.
CC   -!- TISSUE SPECIFICITY: Ubiquitously expressed, with a highest
CC       expression in skeletal muscle. {ECO:0000269|PubMed:7628435}.
CC   -!- SIMILARITY: Belongs to the PI3/PI4-kinase family.
CC       {ECO:0000255|PROSITE-ProRule:PRU00880}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; Z46973; CAA87094.1; -; mRNA.
DR   EMBL; BC033004; AAH33004.1; -; mRNA.
DR   EMBL; BC053651; AAH53651.1; -; mRNA.
DR   CCDS; CCDS11920.1; -.
DR   PIR; S57219; S57219.
DR   RefSeq; NP_002638.2; NM_002647.3.
DR   UniGene; Hs.464971; -.
DR   UniGene; Hs.656958; -.
DR   PDB; 3IHY; X-ray; 2.80 A; A/B/C/D/E=282-879.
DR   PDB; 3LS8; X-ray; 2.25 A; A/B=268-879.
DR   PDB; 4OYS; X-ray; 2.90 A; A=282-879.
DR   PDB; 4PH4; X-ray; 2.80 A; B=293-887.
DR   PDB; 4UWF; X-ray; 2.99 A; A=282-879.
DR   PDB; 4UWG; X-ray; 2.70 A; A=282-879.
DR   PDB; 4UWH; X-ray; 1.93 A; A=282-879.
DR   PDB; 4UWK; X-ray; 2.83 A; A=282-879.
DR   PDB; 4UWL; X-ray; 2.80 A; A=282-879.
DR   PDB; 5ANL; X-ray; 2.70 A; A=282-879.
DR   PDB; 5ENN; X-ray; 2.70 A; A/B=293-887.
DR   PDBsum; 3IHY; -.
DR   PDBsum; 3LS8; -.
DR   PDBsum; 4OYS; -.
DR   PDBsum; 4PH4; -.
DR   PDBsum; 4UWF; -.
DR   PDBsum; 4UWG; -.
DR   PDBsum; 4UWH; -.
DR   PDBsum; 4UWK; -.
DR   PDBsum; 4UWL; -.
DR   PDBsum; 5ANL; -.
DR   PDBsum; 5ENN; -.
DR   ProteinModelPortal; Q8NEB9; -.
DR   SMR; Q8NEB9; -.
DR   BioGrid; 111307; 35.
DR   DIP; DIP-42272N; -.
DR   IntAct; Q8NEB9; 20.
DR   MINT; MINT-1682773; -.
DR   STRING; 9606.ENSP00000262039; -.
DR   BindingDB; Q8NEB9; -.
DR   ChEMBL; CHEMBL1075165; -.
DR   DrugBank; DB06836; N-(5-(4-CHLORO-3-(2-HYDROXY-ETHYLSULFAMOYL)- PHENYLTHIAZOLE-2-YL)-ACETAMIDE.
DR   GuidetoPHARMACOLOGY; 2152; -.
DR   SwissLipids; SLP:000000904; -.
DR   iPTMnet; Q8NEB9; -.
DR   PhosphoSitePlus; Q8NEB9; -.
DR   BioMuta; PIK3C3; -.
DR   DMDM; 74730233; -.
DR   EPD; Q8NEB9; -.
DR   MaxQB; Q8NEB9; -.
DR   PaxDb; Q8NEB9; -.
DR   PeptideAtlas; Q8NEB9; -.
DR   PRIDE; Q8NEB9; -.
DR   DNASU; 5289; -.
DR   Ensembl; ENST00000262039; ENSP00000262039; ENSG00000078142.
DR   GeneID; 5289; -.
DR   KEGG; hsa:5289; -.
DR   UCSC; uc002lap.4; human.
DR   CTD; 5289; -.
DR   DisGeNET; 5289; -.
DR   GeneCards; PIK3C3; -.
DR   HGNC; HGNC:8974; PIK3C3.
DR   HPA; HPA040718; -.
DR   MIM; 602609; gene.
DR   neXtProt; NX_Q8NEB9; -.
DR   OpenTargets; ENSG00000078142; -.
DR   PharmGKB; PA33307; -.
DR   eggNOG; KOG0906; Eukaryota.
DR   eggNOG; COG5032; LUCA.
DR   GeneTree; ENSGT00760000119110; -.
DR   HOGENOM; HOG000174003; -.
DR   HOVERGEN; HBG082145; -.
DR   InParanoid; Q8NEB9; -.
DR   KO; K00914; -.
DR   OMA; WYYVIVE; -.
DR   OrthoDB; EOG091G036A; -.
DR   PhylomeDB; Q8NEB9; -.
DR   TreeFam; TF102032; -.
DR   BioCyc; MetaCyc:HS01275-MONOMER; -.
DR   BRENDA; 2.7.1.137; 2681.
DR   Reactome; R-HSA-109704; PI3K Cascade.
DR   Reactome; R-HSA-1632852; Macroautophagy.
DR   Reactome; R-HSA-1660514; Synthesis of PIPs at the Golgi membrane.
DR   Reactome; R-HSA-1660516; Synthesis of PIPs at the early endosome membrane.
DR   Reactome; R-HSA-1660517; Synthesis of PIPs at the late endosome membrane.
DR   Reactome; R-HSA-168138; Toll Like Receptor 9 (TLR9) Cascade.
DR   Reactome; R-HSA-5668599; RHO GTPases Activate NADPH Oxidases.
DR   SIGNOR; Q8NEB9; -.
DR   ChiTaRS; PIK3C3; human.
DR   EvolutionaryTrace; Q8NEB9; -.
DR   GeneWiki; PIK3C3; -.
DR   GenomeRNAi; 5289; -.
DR   PRO; PR:Q8NEB9; -.
DR   Proteomes; UP000005640; Chromosome 18.
DR   Bgee; ENSG00000078142; -.
DR   CleanEx; HS_PIK3C3; -.
DR   ExpressionAtlas; Q8NEB9; baseline and differential.
DR   Genevisible; Q8NEB9; HS.
DR   GO; GO:0044754; C:autolysosome; IDA:MGI.
DR   GO; GO:0005930; C:axoneme; ISS:UniProtKB.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005770; C:late endosome; IDA:UniProtKB.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0030496; C:midbody; IDA:UniProtKB.
DR   GO; GO:0030670; C:phagocytic vesicle membrane; TAS:Reactome.
DR   GO; GO:0005942; C:phosphatidylinositol 3-kinase complex; IBA:GO_Central.
DR   GO; GO:0035032; C:phosphatidylinositol 3-kinase complex, class III; ISS:UniProtKB.
DR   GO; GO:0016303; F:1-phosphatidylinositol-3-kinase activity; IMP:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0016301; F:kinase activity; IDA:MGI.
DR   GO; GO:0004672; F:protein kinase activity; IEA:Ensembl.
DR   GO; GO:0006914; P:autophagy; IMP:MGI.
DR   GO; GO:0042149; P:cellular response to glucose starvation; ISS:UniProtKB.
DR   GO; GO:0000910; P:cytokinesis; IMP:UniProtKB.
DR   GO; GO:0045022; P:early endosome to late endosome transport; IMP:UniProtKB.
DR   GO; GO:0007032; P:endosome organization; IEA:Ensembl.
DR   GO; GO:0016236; P:macroautophagy; ISS:UniProtKB.
DR   GO; GO:0006661; P:phosphatidylinositol biosynthetic process; TAS:Reactome.
DR   GO; GO:0048015; P:phosphatidylinositol-mediated signaling; IEA:Ensembl.
DR   GO; GO:0006497; P:protein lipidation; IMP:MGI.
DR   GO; GO:0034497; P:protein localization to pre-autophagosomal structure; IEA:Ensembl.
DR   GO; GO:0016485; P:protein processing; IEA:Ensembl.
DR   GO; GO:0032465; P:regulation of cytokinesis; IMP:UniProtKB.
DR   GO; GO:0050708; P:regulation of protein secretion; IEA:Ensembl.
DR   GO; GO:0043201; P:response to leucine; IEA:Ensembl.
DR   GO; GO:0034162; P:toll-like receptor 9 signaling pathway; TAS:Reactome.
DR   Gene3D; 1.10.1070.11; -; 1.
DR   Gene3D; 2.60.40.150; -; 1.
DR   InterPro; IPR016024; ARM-type_fold.
DR   InterPro; IPR000008; C2_dom.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000403; PI3/4_kinase_cat_dom.
DR   InterPro; IPR018936; PI3/4_kinase_CS.
DR   InterPro; IPR002420; PI3K_C2_dom.
DR   InterPro; IPR008290; PI3K_Vps34.
DR   InterPro; IPR015433; PI_Kinase.
DR   InterPro; IPR001263; PInositide-3_kin_accessory_dom.
DR   PANTHER; PTHR10048; PTHR10048; 1.
DR   Pfam; PF00454; PI3_PI4_kinase; 1.
DR   Pfam; PF00792; PI3K_C2; 1.
DR   Pfam; PF00613; PI3Ka; 1.
DR   PIRSF; PIRSF000587; PI3K_Vps34; 1.
DR   SMART; SM00142; PI3K_C2; 1.
DR   SMART; SM00145; PI3Ka; 1.
DR   SMART; SM00146; PI3Kc; 1.
DR   SUPFAM; SSF48371; SSF48371; 2.
DR   SUPFAM; SSF49562; SSF49562; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS00915; PI3_4_KINASE_1; 1.
DR   PROSITE; PS00916; PI3_4_KINASE_2; 1.
DR   PROSITE; PS50290; PI3_4_KINASE_3; 1.
DR   PROSITE; PS51547; PI3K_C2; 1.
DR   PROSITE; PS51545; PIK_HELICAL; 1.
PE   1: Evidence at protein level;
KW   3D-structure; ATP-binding; Autophagy; Cell cycle; Cell division;
KW   Complete proteome; Cytoplasmic vesicle; Endosome; Kinase; Manganese;
KW   Nucleotide-binding; Phosphoprotein; Reference proteome; Transferase.
FT   CHAIN         1    887       Phosphatidylinositol 3-kinase catalytic
FT                                subunit type 3.
FT                                /FTId=PRO_0000088802.
FT   DOMAIN       35    184       C2 PI3K-type. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00880}.
FT   DOMAIN      283    520       PIK helical. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00878}.
FT   DOMAIN      631    885       PI3K/PI4K. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00269}.
FT   MOD_RES     163    163       Phosphothreonine; by AMPK.
FT                                {ECO:0000250|UniProtKB:Q6PF93}.
FT   MOD_RES     165    165       Phosphoserine; by AMPK.
FT                                {ECO:0000250|UniProtKB:Q6PF93}.
FT   MOD_RES     244    244       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:O88763}.
FT   MOD_RES     261    261       Phosphoserine.
FT                                {ECO:0000244|PubMed:19369195}.
FT   MOD_RES     282    282       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   CONFLICT     36     36       K -> N (in Ref. 1; CAA87094).
FT                                {ECO:0000305}.
FT   CONFLICT     70     70       L -> S (in Ref. 1; CAA87094).
FT                                {ECO:0000305}.
FT   CONFLICT    136    136       F -> S (in Ref. 1; CAA87094).
FT                                {ECO:0000305}.
FT   CONFLICT    158    158       K -> N (in Ref. 1; CAA87094).
FT                                {ECO:0000305}.
FT   CONFLICT    208    208       E -> V (in Ref. 1; CAA87094).
FT                                {ECO:0000305}.
FT   CONFLICT    219    220       VE -> GG (in Ref. 1; CAA87094).
FT                                {ECO:0000305}.
FT   CONFLICT    262    262       M -> L (in Ref. 1; CAA87094).
FT                                {ECO:0000305}.
FT   CONFLICT    272    274       KLA -> NLP (in Ref. 1; CAA87094).
FT                                {ECO:0000305}.
FT   CONFLICT    289    292       NAAT -> YPSP (in Ref. 1; CAA87094).
FT                                {ECO:0000305}.
FT   CONFLICT    297    298       NI -> KN (in Ref. 1; CAA87094).
FT                                {ECO:0000305}.
FT   CONFLICT    305    308       TKQL -> SKPP (in Ref. 1; CAA87094).
FT                                {ECO:0000305}.
FT   CONFLICT    318    318       K -> E (in Ref. 1; CAA87094).
FT                                {ECO:0000305}.
FT   CONFLICT    327    327       E -> D (in Ref. 1; CAA87094).
FT                                {ECO:0000305}.
FT   CONFLICT    333    338       FLKCVN -> ILTSVI (in Ref. 1; CAA87094).
FT                                {ECO:0000305}.
FT   CONFLICT    344    344       E -> G (in Ref. 1; CAA87094).
FT                                {ECO:0000305}.
FT   CONFLICT    350    350       E -> A (in Ref. 1; CAA87094).
FT                                {ECO:0000305}.
FT   CONFLICT    356    356       K -> N (in Ref. 1; CAA87094).
FT                                {ECO:0000305}.
FT   CONFLICT    367    367       L -> I (in Ref. 1; CAA87094).
FT                                {ECO:0000305}.
FT   CONFLICT    397    397       L -> S (in Ref. 1; CAA87094).
FT                                {ECO:0000305}.
FT   CONFLICT    428    428       E -> G (in Ref. 1; CAA87094).
FT                                {ECO:0000305}.
FT   CONFLICT    484    484       C -> S (in Ref. 1; CAA87094).
FT                                {ECO:0000305}.
FT   CONFLICT    750    750       L -> V (in Ref. 1; CAA87094).
FT                                {ECO:0000305}.
FT   CONFLICT    826    826       A -> P (in Ref. 1; CAA87094).
FT                                {ECO:0000305}.
FT   HELIX       283    285       {ECO:0000244|PDB:3LS8}.
FT   HELIX       290    300       {ECO:0000244|PDB:4UWH}.
FT   STRAND      304    306       {ECO:0000244|PDB:4UWG}.
FT   HELIX       310    318       {ECO:0000244|PDB:4UWH}.
FT   HELIX       320    323       {ECO:0000244|PDB:4UWH}.
FT   HELIX       327    329       {ECO:0000244|PDB:4UWH}.
FT   HELIX       330    334       {ECO:0000244|PDB:4UWH}.
FT   HELIX       342    352       {ECO:0000244|PDB:4UWH}.
FT   HELIX       360    365       {ECO:0000244|PDB:4UWH}.
FT   HELIX       374    384       {ECO:0000244|PDB:4UWH}.
FT   HELIX       389    402       {ECO:0000244|PDB:4UWH}.
FT   HELIX       403    405       {ECO:0000244|PDB:4UWH}.
FT   HELIX       408    413       {ECO:0000244|PDB:4UWH}.
FT   HELIX       437    439       {ECO:0000244|PDB:4UWH}.
FT   HELIX       442    444       {ECO:0000244|PDB:4UWH}.
FT   TURN        445    447       {ECO:0000244|PDB:4UWH}.
FT   HELIX       475    485       {ECO:0000244|PDB:4UWH}.
FT   HELIX       487    502       {ECO:0000244|PDB:4UWH}.
FT   HELIX       504    509       {ECO:0000244|PDB:4UWH}.
FT   HELIX       511    529       {ECO:0000244|PDB:4UWH}.
FT   HELIX       533    561       {ECO:0000244|PDB:4UWH}.
FT   HELIX       566    578       {ECO:0000244|PDB:4UWH}.
FT   HELIX       580    583       {ECO:0000244|PDB:4UWH}.
FT   STRAND      591    593       {ECO:0000244|PDB:4UWH}.
FT   STRAND      596    604       {ECO:0000244|PDB:4UWH}.
FT   HELIX       606    608       {ECO:0000244|PDB:4UWH}.
FT   STRAND      613    616       {ECO:0000244|PDB:4PH4}.
FT   STRAND      619    625       {ECO:0000244|PDB:4UWH}.
FT   STRAND      630    639       {ECO:0000244|PDB:4UWH}.
FT   HELIX       642    660       {ECO:0000244|PDB:4UWH}.
FT   STRAND      672    683       {ECO:0000244|PDB:4UWH}.
FT   HELIX       690    697       {ECO:0000244|PDB:4UWH}.
FT   HELIX       700    707       {ECO:0000244|PDB:4UWH}.
FT   STRAND      711    713       {ECO:0000244|PDB:4UWH}.
FT   HELIX       714    716       {ECO:0000244|PDB:4UWH}.
FT   HELIX       719    738       {ECO:0000244|PDB:4UWH}.
FT   STRAND      748    751       {ECO:0000244|PDB:4UWH}.
FT   STRAND      757    759       {ECO:0000244|PDB:4UWH}.
FT   STRAND      770    773       {ECO:0000244|PDB:4UWH}.
FT   HELIX       781    787       {ECO:0000244|PDB:4UWH}.
FT   STRAND      790    792       {ECO:0000244|PDB:4UWF}.
FT   HELIX       793    811       {ECO:0000244|PDB:4UWH}.
FT   HELIX       813    821       {ECO:0000244|PDB:4UWH}.
FT   TURN        822    825       {ECO:0000244|PDB:4UWH}.
FT   HELIX       829    832       {ECO:0000244|PDB:4UWH}.
FT   HELIX       835    837       {ECO:0000244|PDB:4UWH}.
FT   HELIX       838    845       {ECO:0000244|PDB:4UWH}.
FT   TURN        846    849       {ECO:0000244|PDB:4UWH}.
FT   HELIX       852    872       {ECO:0000244|PDB:4UWH}.
SQ   SEQUENCE   887 AA;  101549 MW;  1C03D97338E44976 CRC64;
     MGEAEKFHYI YSCDLDINVQ LKIGSLEGKR EQKSYKAVLE DPMLKFSGLY QETCSDLYVT
     CQVFAEGKPL ALPVRTSYKA FSTRWNWNEW LKLPVKYPDL PRNAQVALTI WDVYGPGKAV
     PVGGTTVSLF GKYGMFRQGM HDLKVWPNVE ADGSEPTKTP GRTSSTLSED QMSRLAKLTK
     AHRQGHMVKV DWLDRLTFRE IEMINESEKR SSNFMYLMVE FRCVKCDDKE YGIVYYEKDG
     DESSPILTSF ELVKVPDPQM SMENLVESKH HKLARSLRSG PSDHDLKPNA ATRDQLNIIV
     SYPPTKQLTY EEQDLVWKFR YYLTNQEKAL TKFLKCVNWD LPQEAKQALE LLGKWKPMDV
     EDSLELLSSH YTNPTVRRYA VARLRQADDE DLLMYLLQLV QALKYENFDD IKNGLEPTKK
     DSQSSVSENV SNSGINSAEI DSSQIITSPL PSVSSPPPAS KTKEVPDGEN LEQDLCTFLI
     SRACKNSTLA NYLYWYVIVE CEDQDTQQRD PKTHEMYLNV MRRFSQALLK GDKSVRVMRS
     LLAAQQTFVD RLVHLMKAVQ RESGNRKKKN ERLQALLGDN EKMNLSDVEL IPLPLEPQVK
     IRGIIPETAT LFKSALMPAQ LFFKTEDGGK YPVIFKHGDD LRQDQLILQI ISLMDKLLRK
     ENLDLKLTPY KVLATSTKHG FMQFIQSVPV AEVLDTEGSI QNFFRKYAPS ENGPNGISAE
     VMDTYVKSCA GYCVITYILG VGDRHLDNLL LTKTGKLFHI DFGYILGRDP KPLPPPMKLN
     KEMVEGMGGT QSEQYQEFRK QCYTAFLHLR RYSNLILNLF SLMVDANIPD IALEPDKTVK
     KVQDKFRLDL SDEEAVHYMQ SLIDESVHAL FAAVVEQIHK FAQYWRK
//
